However, the biological function, molecular regulation, substrate specificity, and targeting mechanism of SIAH E3 ligases in the context of constitutive K-RAS activation remains to be characterized in pancreatic cancer. This evidence concerns the gene KRAS and familial pancreatic carcinoma.